◀ Back to NOD1

NOD1 — TRPV1

Text-mined interactions from Literome

Tsui et al., Diabetes Metab Res Rev 2011 (Diabetes Mellitus, Type 1...) : Here, we briefly review the role of TRPV1 in non-obese diabetic ( NOD ) T1D pathogenesis, highlighting commonalities that suggest TRPV1 may contribute to obesity and T2D as well
Tsagogiorgas et al., PloS one 2012 (Acute Kidney Injury) : Since stimulation of transient receptor potential channels of the vanilloid receptor subtype 1 ( TRPV1 ) mitigates acute kidney injury ( AKI ) and endogenous N-acyl dopamine derivatives are able to activate TRPV1, we tested if synthetic N-octanoyl-dopamine ( NOD ) activates TRPV1 and if it improves AKI ... Our data demonstrate that NOD but not DA activates TRPV1 and that NOD has superior anti-inflammatory properties in vitro